Cancer Gene Therapy
Tumor Suppressor p16(INK4a) a Gene Therapy Candidate
Published in Gene Therapy Weekly, September 13th, 1999
J. Lukas and colleagues from the Danish Cancer Society, Denmark, examined p16(INK4a) and pRb genes for their role in oncogenesis. Their results were reported in the journal Oncogene ("p16(INK4a), But Not Constitutively Active pRb, Can Impose a Sustained G1 Arrest: Molecular Mechanisms and Implications for Oncogenesis," Oncogene, July 8, 1999;18(27):3930-3935).
"p16(ink4a) and pRb, two components of a key G1/S regulatory pathway, and tumor suppressors commonly targeted in oncogenesis, are among the candidates for gene therapy of cancer," wrote Lukas et al. ...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1999-09-13)
More Articles from Gene Therapy Weekly
- Gene Delivery (Transgenes)
In utero Gene Delivery Successfully Accomplished in Sheep - Allergy Immunotherapy
Oligodeoxynucleotides Show Promise as Adjuvants - Antisense Therapy (Neurology)
NGF Antisense Oligodeoxynucleotide Is Neuroprotective - Cancer Gene Therapy
Fusion Proteins Can Have Immunomodulating Effect - Cancer Gene Therapy
tPA Gene Transfer Useful against Hepatic Metastasis - Vector Development
HIV Vectors Can Be Maintained without gag and env - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
